Literature DB >> 18568428

The CCN family of genes: a perspective on CCN biology and therapeutic potential.

Herman Yeger1, Bernard Perbal.   

Abstract

The CCN family of genes currently comprises six secreted proteins (designated CCN1-6 after Cyr61/CCN1; ctgf/CCN2; Nov/CCN3; WISP1/CCN4; WISP2/CCN5, WISP3/CCN6) with a similar mosaic primary structure. It is now well accepted that CCN proteins are not growth factors but matricellular proteins that modify signaling of other molecules, in particular those associated with the extracellular matrix. CCN proteins are involved in mitosis, adhesion, apoptosis, extracellular matrix production, growth arrest and migration of multiple cell types. Since their first identification as matricellular factors, the CCN proteins now figure prominently in a variety of major diseases and are now considered valid candidates for therapeutic targeting. Dissection of the molecular mechanisms governing the biological properties of these proteins is being actively pursued by an expanding network of scientists around the globe who will meet this year at the 5th International Workshop on the CCN family of Genes, organized by the International CCN Society ( http://ccnsociety.com ), home for an international cadre of collaborators working in the CCN field.

Entities:  

Year:  2008        PMID: 18568428      PMCID: PMC2443235          DOI: 10.1007/s12079-008-0022-6

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  19 in total

1.  Expression of CCN3 protein in human Wilms' tumors: immunohistochemical detection of CCN3 variants using domain-specific antibodies.

Authors:  Manish Mani Subramaniam; Noureddine Lazar; Samuel Navarro; Bernard Perbal; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2007-12-08       Impact factor: 4.064

2.  Inhibitory effect of CT domain of CCN3/NOV on proliferation and differentiation of osteogenic mesenchymal stem cells, Kusa-A1.

Authors:  Yuko Katsuki; Kei Sakamoto; Tokutaro Minamizato; Hatsune Makino; Akihiro Umezawa; Masa-Aki Ikeda; Bernard Perbal; Teruo Amagasa; Akira Yamaguchi; Ken-Ichi Katsube
Journal:  Biochem Biophys Res Commun       Date:  2008-02-12       Impact factor: 3.575

Review 3.  Mechanical regulation of the Cyr61/CCN1 and CTGF/CCN2 proteins.

Authors:  Brahim Chaqour; Margarete Goppelt-Struebe
Journal:  FEBS J       Date:  2006-07-19       Impact factor: 5.542

4.  CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells.

Authors:  Weike Si; Quan Kang; Hue H Luu; Jong Kyung Park; Qing Luo; Wen-Xin Song; Wei Jiang; Xiaoji Luo; Xinmin Li; Hong Yin; Anthony G Montag; Rex C Haydon; Tong-Chuan He
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

5.  Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61).

Authors:  David R Brigstock
Journal:  Angiogenesis       Date:  2002       Impact factor: 9.596

6.  Functional requirement of CCN2 for intramembranous bone formation in embryonic mice.

Authors:  Harumi Kawaki; Satoshi Kubota; Akiko Suzuki; Tomohiro Yamada; Tatsushi Matsumura; Toshiko Mandai; Mayumi Yao; Takeyasu Maeda; Karen M Lyons; Masaharu Takigawa
Journal:  Biochem Biophys Res Commun       Date:  2007-12-05       Impact factor: 3.575

7.  Domain-specific CCN3 antibodies as unique tools for structural and functional studies.

Authors:  Noureddine Lazar; Cristina Manara; Samuel Navarro; Anne-Marie Bleau; Antonio Llombart-Bosch; Katia Scotlandi; Nathalie Planque; Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2007-09-08       Impact factor: 5.782

8.  Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice.

Authors:  Esther J Kuiper; Peggy Roestenberg; Christoph Ehlken; Vincent Lambert; Henny Bloys van Treslong-de Groot; Karen M Lyons; Hans-Jürgen T Agostini; Jean-Marie Rakic; Ingeborg Klaassen; Cornelis J F Van Noorden; Roel Goldschmeding; Reinier O Schlingemann
Journal:  J Histochem Cytochem       Date:  2007-07-11       Impact factor: 2.479

9.  CYR61/CCN1 and WISP3/CCN6 are chemoattractive ligands for human multipotent mesenchymal stroma cells.

Authors:  Norbert Schütze; Rita Schenk; Jörg Fiedler; Thomas Mattes; Franz Jakob; Rolf E Brenner
Journal:  BMC Cell Biol       Date:  2007-10-31       Impact factor: 4.241

10.  Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene.

Authors:  Emma Heath; Dalal Tahri; Elisabetta Andermarcher; Paul Schofield; Stewart Fleming; Catherine A Boulter
Journal:  BMC Dev Biol       Date:  2008-02-20       Impact factor: 1.978

View more
  43 in total

Review 1.  Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  Adv Drug Deliv Rev       Date:  2016-01-04       Impact factor: 15.470

Review 2.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

3.  CCN3 protein participates in bone regeneration as an inhibitory factor.

Authors:  Yuki Matsushita; Kei Sakamoto; Yoshihiro Tamamura; Yasuaki Shibata; Tokutaro Minamizato; Tasuku Kihara; Masako Ito; Ken-ichi Katsube; Shuichi Hiraoka; Haruhiko Koseki; Kiyoshi Harada; Akira Yamaguchi
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

Review 4.  Programming apoptosis and autophagy with novel approaches for diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

5.  Myeloid deficiency of CCN3 exacerbates liver injury in a mouse model of nonalcoholic fatty liver disease.

Authors:  Wenconghui Wu; Xingjian Hu; Xianming Zhou; Philip A Klenotic; Qi Zhou; Zhiyong Lin
Journal:  J Cell Commun Signal       Date:  2017-12-06       Impact factor: 5.782

6.  Tuberous sclerosis protein 2 (TSC2) modulates CCN4 cytoprotection during apoptotic amyloid toxicity in microglia.

Authors:  Yan Chen Shang; Zhao Zhong Chong; Shaohui Wang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2013-02       Impact factor: 1.990

7.  WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis.

Authors:  Melanie Königshoff; Monika Kramer; Nisha Balsara; Jochen Wilhelm; Oana Veronica Amarie; Andreas Jahn; Frank Rose; Ludger Fink; Werner Seeger; Liliana Schaefer; Andreas Günther; Oliver Eickelberg
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

8.  Matricellular protein CCN3 mitigates abdominal aortic aneurysm.

Authors:  Chao Zhang; Dustin van der Voort; Hong Shi; Rongli Zhang; Yulan Qing; Shuichi Hiraoka; Minoru Takemoto; Koutaro Yokote; Joseph V Moxon; Paul Norman; Laure Rittié; Helena Kuivaniemi; G Brandon Atkins; Stanton L Gerson; Guo-Ping Shi; Jonathan Golledge; Nianguo Dong; Bernard Perbal; Domenick A Prosdocimo; Zhiyong Lin
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

9.  Alternative splicing of CCN mRNAs .... it has been upon us.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2009-04-28       Impact factor: 5.782

10.  Matricellular proteins: an overview.

Authors:  Paul Bornstein
Journal:  J Cell Commun Signal       Date:  2009-09-25       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.